Correlates of receiving recommended adolescent vaccines among adolescent females in North Carolina

Paul L. Reiter, Annie Laurie McRee, Sami L. Gottlieb, Noel T. Brewer

    Research output: Contribution to journalArticlepeer-review

    21 Scopus citations


    Background: Immunization is a successful and cost-effective method for preventing disease, yet many adolescents do not receive recommended vaccines. We assessed correlates of uptake of three vaccines (tetanus booster, meningococcal and human papillomavirus [HPV] vaccines) recommended for adolescent females. Results: Only 17% of parents indicated their daughters had received all three vaccines. Eighty-seven percent of parents indicated their daughters had received tetanus booster vaccine, 36% reported vaccination against meningococcal disease and 36% reported HPV vaccine initiation. Daughters aged 13-15 years (OR = 1.70, 95% CI: 1.09-2.64) or 16-20 years (OR = 2.28, 95% CI: 1.51-3.44) had received a greater number of these vaccines compared to daughters aged 11-12 years. Daughters who had preventive care visits in the last year (OR = 4.81, 95% CI: 3.14-7.34) or whose parents had at least some college education (OR = 1.90, 95% CI: 1.29-2.80) had also received a greater number of these vaccines. Methods: We examined cross-sectional data from 647 parents of 11-20 year-old females from North Carolina who completed the Carolina HPV Immunization Measurement and Evaluation (CHIME) Project follow-up survey in late 2008. Analyses used ordinal and binary logistic regression. Conclusions: Few daughters, particularly 11-12 years olds, had received all three vaccines recommended for adolescent females. Ensuring annual preventive care visits and increasing concomitant administration of adolescent vaccines may help increase vaccine coverage.

    Original languageEnglish (US)
    Pages (from-to)67-73
    Number of pages7
    JournalHuman Vaccines
    Issue number1
    StatePublished - Jan 2011

    Bibliographical note

    Funding Information:
    This study was funded by the Centers for Disease Control and Prevention (S3715-25/25), the American Cancer Society (MSRG-06-259-01-CPPB), and the Cancer Control Education Program at Lineberger Comprehensive Cancer Center (Grant No. R25 CA57726). Although we do not believe we have any conflicts of interest, we wish to share the following information in the interest of full disclosure. Authors have received research grants from Merck & Co., Inc. (N.B. and P.R.) and GlaxoSmithKline (N.B.), but neither has received honoraria or consulting fees from these companies. These funds were not used to support this research study.


    • Adolescents
    • Diphtheria
    • HPV
    • Meningitis
    • Pertussis
    • Tetanus
    • Vaccine

    PubMed: MeSH publication types

    • Journal Article
    • Research Support, N.I.H., Extramural
    • Research Support, Non-U.S. Gov't
    • Research Support, U.S. Gov't, P.H.S.


    Dive into the research topics of 'Correlates of receiving recommended adolescent vaccines among adolescent females in North Carolina'. Together they form a unique fingerprint.

    Cite this